Good Moonwha Hospital completes 100th BioBridge surgical case milestone.

Jul 31, 2025

Fibralign Corp. and its South Korean distributor Healing Solutions, LTD announced today that Good Moonwha Hospital completed its 100th BioBridge case in the surgical treatment of lymphedema. Good Moonhwa is the first medical center in Asia and second worldwide to reach this major milestone, performing the highest number of cases worldwide in the past year.

Since its establishment in 1978, Good Moonhwa Hospital has grown into a general hospital with 16 centers including 17 departments, playing a leading role in developing local care by offering patient-oriented medical services and have emerged into a regional representative general hospital.

 

Japan BioBridge PMDA Study Completion

Japan BioBridge PMDA Study Completion

Terumo Corporation announced that the first clinical trial conducted in Japan for evaluation the BioBridge® Collagen Matrix in the surgical treatment of lymphedema has reached its endpoint. Terumo is managing and funding clinical studies in Japan which are being used...

read more
Fibralign Sponsors International Research Seminar

Fibralign Sponsors International Research Seminar

  Fibralign hosted the Lymphedema Summit on January 23, 2022, an international research seminar focused on “Advancements in Lymphedema Surgical Treatment.” This special event featured a gathering of the leading surgeons and researchers in this field and took...

read more